| Drug Humira Can Cause Permanent Damage to Optic Nerves |
Lawsuits have been filed throughout the country by people whose optic nerves were permanently damaged by Humira, generic name Adalimumab. While similar drugs have a specific warning about the risks of optic nerve damage, Humira does not.
Humira, manufactured by Abbott Laboratories, is one of the most lucrative drugs on the market, with 2010 worldwide sales of $6.5 billion. Humira was originally approved in 2003 as a treatment for rheumatoid arthritis. The FDA has since approved it for treatment of five additional autoimmune diseases: psoriatic arthritis, ankylosing spondylitis, Crohn's disease, moderate to severe chronic psoriasis, and juvenile idiopathic arthritis.
In addition to permanent damage to the optic nerve, lawsuits have also been filed by people who allege their use of Humira caused cancer and peripheral nerve damage. |